Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myt1 is a neural-specific protein with dual functions as a transcription factor and a kinase. It regulates myelin gene expression and inhibits Cdk1 to control cell cycle progression. Its roles in neurodevelopment and cell cycle make it a potential therapeutic target for neurodevelopmental disorders, demyelinating diseases, and cancer.
Phosphorylation and inhibition of Cdk1
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myelin transcription factor 1 kinase (Myt1).